Symbol="EDSA"
AssetType="Common Stock"
Name="Edesa Biotech Inc"
Description="Edesa Biotech, Inc., a clinical-stage biopharmaceutical company, is engaged in the research and development, manufacture and marketing of pharmaceuticals for inflammatory and immune-related diseases. The company is headquartered in Markham, Canada."
CIK="1540159"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="PHARMACEUTICAL PREPARATIONS"
Address="332 EAST SCOTT STREET, PORT HUENEME, CA, US"
FiscalYearEnd="September"
LatestQuarter="2023-03-31"
MarketCapitalization="20381800"
EBITDA="-13319690"
PERatio="None"
PEGRatio="None"
BookValue="0.449"
DividendPerShare="0"
DividendYield="0"
EPS="-0.61"
RevenuePerShareTTM="0"
ProfitMargin="0"
OperatingMarginTTM="0"
ReturnOnAssetsTTM="-0.54"
ReturnOnEquityTTM="-1.02"
RevenueTTM="500"
GrossProfitTTM="311200"
DilutedEPSTTM="-0.61"
QuarterlyEarningsGrowthYOY="0"
QuarterlyRevenueGrowthYOY="-0.999"
AnalystTargetPrice="11.67"
TrailingPE="-"
ForwardPE="0.172"
PriceToSalesRatioTTM="120477.93"
PriceToBookRatio="1.422"
EVToRevenue="128525.38"
EVToEBITDA="-0.223"
Beta="0.747"
num_52WeekHigh="2.81"
num_52WeekLow="0.76"
num_50DayMovingAverage="0.849"
num_200DayMovingAverage="1.133"
SharesOutstanding="20587700"
DividendDate="2019-06-10"
ExDividendDate="None"
symbol="EDSA"
open="0.81"
high="0.99"
low="0.81"
price="0.99"
volume="142555.00"
latest_trading_day="2023-08-03"
previous_close="0.82"
change="0.17"
change_percent="20.0000%"
aroon_positive_momentum_days="0"
aroon_negative_momentum_days="93"
trend_strength="Absent or Weak Trend"
buying_signal="Strong Sell Signal"
volume_analysis="Target Volume"
value_analysis="Expected Range"
Aroon_change="FALSE"
Aroon_momentum="7"
Volume_recent_avg="71962"
Change_recent_avg="-0.01"
Delta_recent_avg="0.06"
Variance_recent_avg="0.03"
Change_ratio_recent_avg="-0.62"
RSI_change="FALSE"
ADX_change="FALSE"

event="FALSE"
Aroon_signal="negative"
Aroon_change="FALSE"
Aroon_momentum_positive="7"
Aroon_momentum_negative="93"
image_negative_thumbnail_id_1="489"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0116.jpeg"
image_negative_thumbnail_id_2="161"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/05/MI_Finance_Negative_Landscape_0015.jpeg"
image_neutral_thumbnail_id_1="525"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0074.jpeg"
image_neutral_thumbnail_id_2="574"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0025.jpeg"
image_positive_thumbnail_id_1="649"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0059.jpeg"
image_positive_thumbnail_id_2="618"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0090.jpeg"
image_professor_thumbnail_id_1="1193"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0027.jpeg"
image_professor_thumbnail_id_2="1179"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0013.jpeg"
